High Efficacy Treatments in MS

High Efficacy Treatments in MS

Dr. Montalban reviews therapies for treatment of patients with MS, including Fingolimod, Natalizumab, Alemtuzmab, and Cladribine.
  • Overview

    In this episode of MS Talks, Dr. Xavier Montalban reviews four of the 2nd line pharmacologic therapies for MS, including Fingolimod, Natalizumab, Alemtuzmab, and Cladribine.

  • Commercial Support

    This activity is supported by an independent educational grant from Merck KGaA, Darmstadt, Germany.

Facebook Comments

Sign-up for the Global Neurology Academy newsletters.
Comprehensive Neurology Education.

Better education for a better you.

* Required
Optional